<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Daily Stocks News &#187; ARQL</title>
	<atom:link href="http://news.dailystocks.com/tag/arql/feed/" rel="self" type="application/rss+xml" />
	<link>http://news.dailystocks.com</link>
	<description>Stocks with Insider Buying, Stock Search Engine, Glossary, Education, Reviews</description>
	<lastBuildDate>Mon, 21 Jan 2019 17:42:26 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>CEO Paolo Pucci, Arqule, Inc. Insider Buys $21,000 of Shares on 03/13/2014</title>
		<link>http://news.dailystocks.com/4309/4309/</link>
		<comments>http://news.dailystocks.com/4309/4309/#comments</comments>
		<pubDate>Tue, 08 Apr 2014 13:31:38 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Insider Buying]]></category>
		<category><![CDATA[ARQL]]></category>
		<category><![CDATA[Arqule]]></category>
		<category><![CDATA[Inc.]]></category>
		<category><![CDATA[Paolo Pucci]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=4309</guid>
		<description><![CDATA[<p>Paolo Pucci, CEO of Arqule, Inc., bought 10,000 shares of Arqule, Inc. (ARQL: 10,000) at $2.1 per share for a total amount of $21,000 thousand on 03/13/2014. </p> <p>Arqule, Inc. is located in Woburn, MA.</p> <p>On 04/02/2014, Arqule, Inc. announced that the Company will present at the Needham 13th Annual Healthcare Conference on Wednesday, April [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/4309/4309/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Major Movers on January 11; DNDN, BBY, KBR, INFY, ARQL, JCP, WFC</title>
		<link>http://news.dailystocks.com/2204/major-movers-on-january-11-dndn-bby-kbr-infy-arql-jcp-wfc/</link>
		<comments>http://news.dailystocks.com/2204/major-movers-on-january-11-dndn-bby-kbr-infy-arql-jcp-wfc/#comments</comments>
		<pubDate>Fri, 11 Jan 2013 17:57:20 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[ARQL]]></category>
		<category><![CDATA[BBY]]></category>
		<category><![CDATA[DNDN]]></category>
		<category><![CDATA[INFY]]></category>
		<category><![CDATA[JCP]]></category>
		<category><![CDATA[KBR]]></category>
		<category><![CDATA[WFC]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=2204</guid>
		<description><![CDATA[<p>Shares of Dendreon Corporation (NASDAQ: DNDN) rallied on Friday after analysts at Bernstein Research boosted its rating on the pharmaceutical company to “outperform” and raised its price target on stock by 43% to $10, citing upbeat outlook on company’s prostate cancer treatment. The 52-week trading of the stock is $5.73-$6.02.</p> <p></p> <p>Shares of consumers electronic [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/2204/major-movers-on-january-11-dndn-bby-kbr-infy-arql-jcp-wfc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
